Cannabidiol shows promise in treating cognitive disorders

Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.

Are Athletes With T1D Putting Themselves at Risk for Recurrent Hypoglycemia?

CHICAGO – Nearly three-fourths of people with type 1 diabetes (T1D) who engaged in aerobic activity failed to follow guidelines for preventing hypoglycemia, according to

June 19, 2023

Bausch + Lomb considers sale: FT

Dive Brief: Bausch + Lomb is exploring a potential sale that would separate the eye care company from parent firm Bausch Health, the Financial Times

September 16, 2024

J&J’s Janssen nabs new indication, full approval for cancer drug Rybrevant

Johnson & Johnson’s Janssen on Friday earned an FDA approval for its cancer drug Rybrevant (amivantamab-vmjw) for the first-line treatment of locally advanced or metastatic

March 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.